<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01580098</url>
  </required_header>
  <id_info>
    <org_study_id>D250487</org_study_id>
    <nct_id>NCT01580098</nct_id>
  </id_info>
  <brief_title>Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus</brief_title>
  <acronym>RenewingHealth</acronym>
  <official_title>Regions of Europe Working Together for Health (Renewing Health)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Landeskrankenanstalten-Betriebsgesellschaft</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Landeskrankenanstalten-Betriebsgesellschaft</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation whether the introduction of large-scale personalized and technology supported
      telemonitoring and health coaching interventions produces benefits in terms of health related
      quality of life, health status and empowerment of patients with type 2 diabetes mellitus. In
      addition, the trials evaluate the economical and organizational impact of the new services
      and examine their acceptability by patients and health professionals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health Related Quality of Life as Measured by the Short Form 36 Version 2 Questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status.
Mearurement at the beginning and after 12 months, Scales from 0 to 100, higher values represent a better outcome; Data are mean scores (SD); differences between groups after 12 month were compared by using Mann-Whitney-U-tests.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>12 months</time_frame>
    <description>HbA1c was taken at the beginning of the study and after 12 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Lipids</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Weight</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Changes</measure>
    <time_frame>12 months</time_frame>
    <description>Insulin, Change? -&gt; Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Diabetic Complications</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Hospitalisations</measure>
    <time_frame>12 months</time_frame>
    <description>The number of inpatient stays comparing intervention and control group was conducted.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">193</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>treatment as usual</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Self-monitoring for patients with Diabetes mellitus type 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are self-monitoring and submitting their vital parameters.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nurse-monitoring for patients with Diabetes mellitus type 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nurses are measuring and entering the vital parameters of the patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Self-monitoring for patients with Diabetes mellitus type 2</intervention_name>
    <description>Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.</description>
    <arm_group_label>Self-monitoring for patients with Diabetes mellitus type 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nurse-monitoring for patients with Diabetes mellitus type 2</intervention_name>
    <description>Nurses are submitting the vital parameters of the patient via mobile device.</description>
    <arm_group_label>Nurse-monitoring for patients with Diabetes mellitus type 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  T2DM diagnosed &gt; 3 months prior to the enrollment

          -  HbA1c &gt;= 6,5 %

          -  Capability of filling questionnaires by their own language

          -  Being able to use the devices provided

          -  Being cognitively able to participate

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Klinikum Klagenfurt</name>
      <address>
        <city>Klagenfurt</city>
        <state>Carinthia</state>
        <zip>9020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LKH Laas</name>
      <address>
        <city>KÃ¶tschach</city>
        <state>Carinthia</state>
        <zip>9640</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LKH Villach</name>
      <address>
        <city>Villach</city>
        <state>Carinthia</state>
        <zip>9500</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2012</study_first_submitted>
  <study_first_submitted_qc>April 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2012</study_first_posted>
  <results_first_submitted>April 8, 2015</results_first_submitted>
  <results_first_submitted_qc>August 21, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 23, 2015</results_first_posted>
  <last_update_submitted>August 21, 2015</last_update_submitted>
  <last_update_submitted_qc>August 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>treatment as usual</description>
        </group>
        <group group_id="P2">
          <title>Self-monitoring for Patients With Diabetes Mellitus Type 2</title>
          <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.</description>
        </group>
        <group group_id="P3">
          <title>Nurse-monitoring for Patients With Diabetes Mellitus Type 2</title>
          <description>nurse-monitoring for patients with Diabetes Mellitus
Nurses are entering vital parameters of the patient with mobile devices</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="114"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="101"/>
                <participants group_id="P3" count="0">Due to high age and bad health conditions no patients finished (nursing)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>treatment as usual</description>
        </group>
        <group group_id="B2">
          <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
          <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="76"/>
            <count group_id="B2" value="117"/>
            <count group_id="B3" value="193"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.38" spread="11.13"/>
                    <measurement group_id="B2" value="60.35" spread="11.68"/>
                    <measurement group_id="B3" value="61.54" spread="11.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Health Related Quality of Life as Measured by the Short Form 36 Version 2 Questionnaire</title>
        <description>The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status.
Mearurement at the beginning and after 12 months, Scales from 0 to 100, higher values represent a better outcome; Data are mean scores (SD); differences between groups after 12 month were compared by using Mann-Whitney-U-tests.</description>
        <time_frame>12 months</time_frame>
        <population>No patients of the Nurse-Monitoring Group finished the study, as a consequence no SF36 after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters. Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>Health Related Quality of Life as Measured by the Short Form 36 Version 2 Questionnaire</title>
          <description>The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status.
Mearurement at the beginning and after 12 months, Scales from 0 to 100, higher values represent a better outcome; Data are mean scores (SD); differences between groups after 12 month were compared by using Mann-Whitney-U-tests.</description>
          <population>No patients of the Nurse-Monitoring Group finished the study, as a consequence no SF36 after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
          <units>units on a scale (General health score)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physical Functioning 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.2" spread="25.8"/>
                    <measurement group_id="O2" value="72.5" spread="25.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Functioning 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.9" spread="24.1"/>
                    <measurement group_id="O2" value="77.1" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Physical 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.5" spread="29.5"/>
                    <measurement group_id="O2" value="63.8" spread="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Physical 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.3" spread="29.3"/>
                    <measurement group_id="O2" value="72.5" spread="25.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily Pain 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.8" spread="33.6"/>
                    <measurement group_id="O2" value="62.2" spread="31.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily Pain 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" spread="30.9"/>
                    <measurement group_id="O2" value="66.5" spread="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General Health 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.6" spread="19.3"/>
                    <measurement group_id="O2" value="62.2" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General Health 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.9" spread="17.9"/>
                    <measurement group_id="O2" value="69.4" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.3" spread="25.7"/>
                    <measurement group_id="O2" value="58.4" spread="62.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.6" spread="23.6"/>
                    <measurement group_id="O2" value="63.2" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Functioning 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.1" spread="23.1"/>
                    <measurement group_id="O2" value="81.3" spread="22.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Functioning 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.7" spread="18.8"/>
                    <measurement group_id="O2" value="81.3" spread="26.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Emotional 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.5" spread="28.2"/>
                    <measurement group_id="O2" value="70.7" spread="24.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Emotional 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.7" spread="28.4"/>
                    <measurement group_id="O2" value="78.7" spread="25.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Health 0-100 Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.2" spread="21.7"/>
                    <measurement group_id="O2" value="72.1" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Health 0-100 Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.1" spread="19.6"/>
                    <measurement group_id="O2" value="72.6" spread="20.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCS Physical Component Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.7" spread="10.4"/>
                    <measurement group_id="O2" value="45.1" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCS Physical Component Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.3" spread="9.6"/>
                    <measurement group_id="O2" value="47.9" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MCS Mental Component Score baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.2" spread="11.9"/>
                    <measurement group_id="O2" value="47.9" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MCS Mental Component Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.6" spread="11.9"/>
                    <measurement group_id="O2" value="49.1" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>HbA1c</title>
        <description>HbA1c was taken at the beginning of the study and after 12 months.</description>
        <time_frame>12 months</time_frame>
        <population>No patients of the Nurse-Monitoring Group finished the study, as a consequence no HbA1c after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>HbA1c</title>
          <description>HbA1c was taken at the beginning of the study and after 12 months.</description>
          <population>No patients of the Nurse-Monitoring Group finished the study, as a consequence no HbA1c after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
          <units>HbA1c [%]</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HbA1c values: first examination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="1.2"/>
                    <measurement group_id="O2" value="8.7" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HbA1c values after 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" spread="1.1"/>
                    <measurement group_id="O2" value="7.5" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.025</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Pressure</title>
        <time_frame>12 months</time_frame>
        <population>Not all Participants delivered data, reliable data was used. No patients of the Nurse-Monitoring Group finished the study, as a consequence no blood pressure after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure</title>
          <population>Not all Participants delivered data, reliable data was used. No patients of the Nurse-Monitoring Group finished the study, as a consequence no blood pressure after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>diastolic baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.7" spread="12.9"/>
                    <measurement group_id="O2" value="88.9" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>systolic baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150.4" spread="21.3"/>
                    <measurement group_id="O2" value="153.7" spread="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>diastolic after 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.2" spread="13.0"/>
                    <measurement group_id="O2" value="84.8" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>systolic after 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="149.3" spread="21.1"/>
                    <measurement group_id="O2" value="148.7" spread="23.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Blood pressure: diastolic</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.182</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Lipids</title>
        <time_frame>12 months</time_frame>
        <population>Not all Participants delivered reliable data; Measurements at the beginning of the trial and after 12 months; No patients of the Nurse-Monitoring Group finished the study, as a consequence no blood lipids after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Lipids</title>
          <population>Not all Participants delivered reliable data; Measurements at the beginning of the trial and after 12 months; No patients of the Nurse-Monitoring Group finished the study, as a consequence no blood lipids after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>LDL Cholesterol after 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.3" spread="38.7"/>
                    <measurement group_id="O2" value="107.6" spread="44.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDL Cholesterol baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.5" spread="36.3"/>
                    <measurement group_id="O2" value="112.1" spread="42.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cholesterol after 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="185.2" spread="41.6"/>
                    <measurement group_id="O2" value="186.1" spread="51.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cholesterol after baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="186.8" spread="37.8"/>
                    <measurement group_id="O2" value="197.6" spread="53.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL-cholesterol after 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.3" spread="17.6"/>
                    <measurement group_id="O2" value="48.1" spread="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL-cholesterol baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.2" spread="16.8"/>
                    <measurement group_id="O2" value="47.1" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Weight</title>
        <time_frame>12 months</time_frame>
        <population>baseline demographic characteristics; No patients of the Nurse-Monitoring Group finished the study, as a consequence no Body weight after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>Body Weight</title>
          <population>baseline demographic characteristics; No patients of the Nurse-Monitoring Group finished the study, as a consequence no Body weight after 12 months were delivered, so a calculation and evaluation for this group could not be conducted.</population>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>body weight baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.2" spread="19.0"/>
                    <measurement group_id="O2" value="90.74" spread="20.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>body weight after 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.22" spread="19.32"/>
                    <measurement group_id="O2" value="91.64" spread="19.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Medication Changes</title>
        <description>Insulin, Change? -&gt; Yes/No</description>
        <time_frame>12 months</time_frame>
        <population>No data about medical changes could be analysed at the end of the study, no data were collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Changes</title>
          <description>Insulin, Change? -&gt; Yes/No</description>
          <population>No data about medical changes could be analysed at the end of the study, no data were collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Diabetic Complications</title>
        <time_frame>12 months</time_frame>
        <population>No data about the presence of diabetic complications could be analysed at the end of the study, no data was collected for this secondary outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Diabetic Complications</title>
          <population>No data about the presence of diabetic complications could be analysed at the end of the study, no data was collected for this secondary outcome.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Hospitalisations</title>
        <description>The number of inpatient stays comparing intervention and control group was conducted.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>treatment as usual</description>
          </group>
          <group group_id="O2">
            <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
            <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Hospitalisations</title>
          <description>The number of inpatient stays comparing intervention and control group was conducted.</description>
          <units>number of inpatient stays</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.63"/>
                    <measurement group_id="O2" value="0.38" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>treatment as usual</description>
        </group>
        <group group_id="E2">
          <title>Self-monitoring and Nurse Monitoring Diabetes Mellitus Type 2</title>
          <description>Patients are self-monitoring and submitting their vital parameters.
Self-monitoring for patients with Diabetes mellitus type 2: Patients are submitting their vital parameters via a Web Portal or automatic devices to the hospital.
Home nursing is also included. Nurses are measuring and entering the vital parameters of the patients.
Nurse-monitoring for patients with Diabetes mellitus type 2: Nurses are submitting the vital parameters of the patient via mobile device.
No patients using the mobile nursing finished the study, so in the final statistical analysis they were not analysed as separate arm.
Due to low enrollement in the Nurse Monitoring arm, it is combined in this module.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Hannes Steinberger</name_or_title>
      <organization>Landeskrankenanstalten-Betriebsgesellschaft</organization>
      <phone>+4346355212 50303</phone>
      <email>hannes.steinberger@kabeg.at</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

